We keep regular tabs on the market trends by attending a collection of events both big and small around the world. Check below for our latest schedule.
Reach out to schedule a meeting in-person if we’ll be at the same event!
Reach Out
A Few Words From Our Founder
“With the onslaught of various AI tools and the increased digitization of vendor-customer interactions in B2B life science, is there still room for face-to-face events in 2026? My answer is a resounding YES! In fact, I am more convinced than ever the pleasures of having “real life” conversations with exhibitor experts, viewing tactile scientific posters, querying presenters in front of a live audience, exchanging physical business cards, and sharing a meal with a new colleague emanates positive industry vibes that simply cannot be replicated in the digital world.
As for the bioprocess market? Tumultuous, to say the least, but here is our take: the mega bioprocess suppliers and CDMOs are projecting high single-digit to low double-digit sales growth as they tally their 2025 revenues – with continued growth in 2026 and beyond. Liquidity is trickling back into the venture capital markets after two cold years, prioritizing quality over quantity. Unmet needs in bioprocess tools and tech still abound across all modalities. While maintaining budget discipline is incredibly important, err on the side of attending that extra event this year. You might be pleasantly surprised at what you learn or who you meet.”
Kimo Sanderson
Founder & Technical Director
About This Event
A combination of partnering and exhibition, ATW (or “Phacilitate” to the industry veterans) is an event that highlights the latest in cell and gene therapy business and market trends. This is not a technical forum but rather provides a broad overview of the CGT industry while affording good networking opportunities.
Who Attends
CGT developers; CGT tools and service providers; investors.
About This Event
TIDES Asia is a Japan-focused event for peptide and oligonucleotide-based therapeutics that still brings a global flavor. More recently, mRNA and gene- editing content has also been included. A scientific program including posters and oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. A small but growing exhibition for peptide/oligo/mRNA tools and service providers reflects the emergence of oligos and mRNA in Japan and throughout Asia.
Who Attends
Peptide, oligo, and mRNA developers, suppliers, and service providers; engineering companies; academics.
About This Event
The largest and most comprehensive event for biotechnology, with over 20,000 participants from around the world. The Tokyo instance of this exhibition series attracts a very broad audience – including business development as well as scientific attendees. Pharma ingredients, machinery and outsourcing are all well represented.
Who Attends
Big Pharma and small biotech searching for licensing partners or investment; suppliers and service providers promoting their capabilities; investors; legal/IP firms; other business service firms.
About This Event
The so-called “largest event dedicated to peptide and oligonucleotide- based therapeutics,” TIDES USA is a renowned global event for oligos and peptides. More recently, mRNA and gene- editing content has also been included. A strong scientific program including posters and high-profile oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. An impressive exhibition landscape for peptide/oligo/ mRNA tools and service providers. Highly recommended if you wish to learn about this space.
Who Attends
Peptide, oligo, and mRNA developers, suppliers, and service providers; engineering companies; academics.
About This Event
Branded as “Asia’s Leading Pharma & Bio Tech Show,” INTERPHEX WEEK TOKYO is actually a compilation of several specialized shows under one roof at Tokyo’s Big Sight exhibition hall. Namesake show INTERPHEX JAPAN is the leading expo for pharmaceutical manufacturing, packaging and contract manufacturing. in-PHARMA JAPAN focuses on APIs, intermediates, and ingredients for pharmaceuticals and cosmetics. BioPharma EXPO is Japan’s largest show for biopharmaceutical R&D, manufacturing technology, CROs, and CDMOs. PharmaLab EXPO focuses on laboratory and drug discovery technology. Finally, at the Regenerative Medicine EXPO you will find the latest tools, technologies, products and services for regenerative medicine and tissue engineering. In total, over 900 exhibitors and over 34,000 visitors will attend. Keynotes and presentations are also showcased, with many of them bilingual to cater to the ever-increasing global audience.
Who Attends
Pharma, biopharma, and CGT developers, suppliers, and service providers; engineering companies; distributors; trading companies.
About This Event
The largest and most comprehensive event for biotechnology, with over 20,000 participants from round the world. A massive exhibition with a very broad audience – much more business- oriented than technical. Expect business development and corporate types more than research scientists and process engineers – but good for networking in that regard.
Who Attends
Big pharma and small biotech searching for licensing partners or investment; suppliers and service providers promoting their capabilities; investors; legal/IP firms; other business service firms.
About This Event
The 11th Annual Meeting of the Japanese Society of Nucleic Acid Medicines promotes research and education on nucleic acid medicines, with the aim of contributing to the creation of such medicines in Japan. The annual meeting provides a venue for experts working in five areas – chemistry, biology, delivery, medicine and clinical practice, and regulatory science – to disseminate and share their latest research results. Oral presentations as well as an exhibition are included.
Who Attends
A cooperative event with participants from both academia and industry, all with interests furthering the realization of nucleic acid therapeutics.
About This Event
A twofer: “BPI” is the original bioprocessing event which covers development and manufacturing of biologics and is co-located with the CGT Manufacturing & Commercialization which specifically covers cell and gene therapies. The scientific programs include posters and multiple streams of oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. The joint exhibition includes both bioprocessing and CGT tools and service providers.
Who Attends
Biologics and CGT developers; bioprocess and CGT tools and service providers; engineering companies; investors.
About This Event
BioJapan is Asia’s premier bio-industry partnering event and the world’s longest-running biotech exhibition. The program includes an exhibition, seminars, and partnering sessions, alongside two co-located events: Regenerative Medicine Japan, accelerating R&D and commercialization in regenerative medicine, and healthTECH Japan, highlighting health management, diagnostics, and therapeutics through the integration of digital technology and life sciences. A central hub for global collaboration and innovation in biotech.
Who Attends
Biotech and pharma companies, regenerative medicine developers, health tech innovators, investors, service providers, and academic researchers.